[Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].

The changes in the blood level of fibrin-fibrinogen degradation products (FDP) have been studied in 62 patients with myocardial infarction. 30 healthy donors served as the control. FDP was determined using solid-phase immunoenzyme assay. Acute and subacute phases of myocardial infarction were characterized by an increase in FDP blood level. However, in severe cases a possible low FDP blood level in conditions of fibrinolysis depression may be associated with an increased risk of severe thromboembolic complications.